Multifunctional liposomes containing Rh2 [150] can easily interact with tumor cells through glucose transporters (GLUT), effectively inhibiting the growth of breast cancer by reshaping the cellular composition of the tumor microenvironment and reversing the immunosuppressive environment. The gene discussed is SLC2A1; the disease is neoplasm.